JDBIO Participates in the ‘Paris IMCAS World Congress 2026’
Expanding Global Influence with K-Medical Beauty Fillers, Toxins, and Exosome Solutions
JDBIO strengthened its brand competitiveness in the global medical beauty market by participating in the world-renowned medical aesthetics conference, Paris IMCAS World, held in Paris, France.
IMCAS (World Congress of Interdisciplinary Aesthetic & Anti-Aging Medicine) is one of the largest international conferences covering dermatology, plastic surgery, aesthetic medicine, and anti-aging. Every year, medical professionals and global medical aesthetics companies from around the world gather at this prestigious event. This year, numerous global companies and medical experts attended to share the latest clinical research results, innovative treatment trends, and next-generation aesthetic medicine solutions.
During the event, a wide range of academic lectures, live demonstrations, and hands-on workshops were held. Medical professionals were able to directly explore the latest trends in dermal filler procedures, botulinum toxin protocols, and skin regeneration and anti-aging solutions.
Global Attention on Filler, Toxin, and Exosome-Focused Products
At the IMCAS congress, JDBIO showcased its core medical aesthetic lineup, including RICHESSE™ - Hyaluronic Acid Filler, One Tox® - Botulinum Toxin, DEMEI™ - Hyaluronic Acid Filler, JADE™, Exo'One - Exosome, OneFill™ - HA Dermal Filler, and PDRN/PN Booster, receiving high interest from global medical professionals and buyers.
In particular, premium fillers and botulinum toxin products aligned with global trends emphasizing natural results, as well as exosome, PDRN/PN, and NAD+-based solutions for skin regeneration and anti-aging, drew active consultations and positive evaluations on site. Products specialized for facial contouring, skin elasticity restoration, and rejuvenation were recognized for their strong competitiveness by medical professionals from various countries.
During the exhibition, JDBIO conducted numerous business meetings with clinics and potential distribution partners from Europe, the Middle East, Asia, and the Americas, expanding its global network. This allowed the company to gain insights into country-specific market characteristics and treatment trends, and to further refine product strategies for fillers, toxins, and skin boosters tailored to each region.
In addition, through various academic sessions held during the congress, JDBIO deepened its understanding of the latest anti-aging research trends and next-generation skin regeneration technologies, which will be actively applied in future product development and global marketing strategies.
JDBIO has solidified its position as a K-medical beauty brand in the global medical aesthetics market through its participation in Paris IMCAS World and plans to continue engaging with major international conferences and exhibitions to further expand its global presence.